These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23691485)

  • 21. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells.
    Xie R; Liu J; Yu X; Li C; Wang Y; Yang W; Hu J; Liu P; Sui H; Liang P; Huang X; Wang L; Bai Y; Xue Y; Zhu J; Fang T
    J Oncol; 2019; 2019():4035460. PubMed ID: 31186633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein phosphorylation and its role in the regulation of Annexin A2 function.
    Grindheim AK; Saraste J; Vedeler A
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2515-2529. PubMed ID: 28867585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma.
    Xiao L; Jin H; Duan W; Hou Y
    Life Sci; 2020 Jul; 253():117740. PubMed ID: 32376265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells.
    Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
    Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
    Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans.
    Fang W; Fa ZZ; Xie Q; Wang GZ; Yi J; Zhang C; Meng GX; Gu JL; Liao WQ
    CNS Neurosci Ther; 2017 Apr; 23(4):291-300. PubMed ID: 28130864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour].
    Zhang H; Yao M; Qian Q; Shi Y; Li J; Chen X; Wang S; Yao D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):620-4. PubMed ID: 25243965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of serine phosphorylation and Ser25 phospho-mimicking mutations on nuclear localisation and ligand interactions of annexin A2.
    Grindheim AK; Hollås H; Ramirez J; Saraste J; Travé G; Vedeler A
    J Mol Biol; 2014 Jun; 426(13):2486-99. PubMed ID: 24780253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
    Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
    Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin.
    Chen Y; Wen X; Wang Z; Zeng J; Chen B; Yang Y; Lu K; Gu J; Yi B
    Biochem Biophys Res Commun; 2016 Jan; 469(1):70-75. PubMed ID: 26616057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
    Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
    Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin A2-S100A10 Represents the Regulatory Component of Maxi-Cl Channel Dependent on Protein Tyrosine Dephosphorylation and Intracellular Ca²⁺.
    Islam MR; Okada T; Merzlyak PG; Toychiev AH; Ando-Akatsuka Y; Sabirov RZ; Okada Y
    Cell Physiol Biochem; 2020 May; 54(4):538-555. PubMed ID: 32442363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Honokiol inhibits the growth of SKBR3 cells.
    Shi H; Wang Y; Yao M; Zhang D; Fang W; Zhou T; Gan D; Yue S; Qian H; Chen T
    Transl Cancer Res; 2020 Dec; 9(12):7596-7604. PubMed ID: 35117359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.
    Zhang Y; Bi J; Zhu H; Shi M; Zeng X
    Biosci Biotechnol Biochem; 2018 Oct; 82(10):1733-1741. PubMed ID: 29912633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells.
    Shetty P; Bargale A; Patil BR; Mohan R; Dinesh US; Vishwanatha JK; Gai PB; Patil VS; Amsavardani TS
    Mol Cell Biochem; 2016 Jan; 411(1-2):221-33. PubMed ID: 26438086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
    Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH
    Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.